Table 2

 Differences in incidence of BRAF or BRAF/NRAS mutations in various types of non-cutaneous melanomas (present study) compared with primary cutaneous melanomas (from the literature)

Melanoma typeIncidence of BRAF mutationp Value*Combined incidence of BRAF/NRAS mutationsp Value*
*Comparison of each category against primary cutaneous melanomas using Fisher’s exact test.
†Literature data were pooled from the references.
Primary cutaneous melanoma178/444 (40.1%)10,12,15,18,20,22–28111/141 (78.7%)10,22–24,28
Malignant melanoma of soft parts0/7 (0%)0.0290/7 (0%)<0.0001
Mucosal melanomas2/36 (5.6%)<0.00017/36 (19.4%)<0.0001
Uveal melanomas0/6 (0%)0.0481/6 (16.7%)0.0029
All non-cutaneous melanomas2/51 (3.9%)<0.00019/51 (17.6%)<0.0001